🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

RecruitingPhase 1, Phase 2Ages 18 Years - anyAllThomas Advanced Medical LLC
NCT04684602 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 and older * Ability to provide informed consent * Availability for follow up visits Exclusion Criteria: * Active or recent malignancy (within last 2 years) * Pregnancy or breast-feeding * Inability to provide informed consent
💊

What it tests

  • PrimePro™/ PrimeMSK™
📍

Where

1 site
Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites
Culver City, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy